tiprankstipranks
Nanjing Leads Biolabs Co., Ltd. Class H (HK:9887)
:9887
Hong Kong Market
9887
Nanjing Leads Biolabs Co., Ltd. Class H
RESEARCH TOOLSreports

Nanjing Leads Biolabs Co., Ltd. Class H (9887) Stock News & Sentiment

0 Followers
Nanjing Leads Biolabs Advances Key Bispecific Antibody Into Phase II Expansion for Biliary Tract Cancer
Premium
Company Announcements
Nanjing Leads Biolabs Advances Key Bispecific Antibody Into Phase II Expansion for Biliary Tract Cancer
7d ago
9887
Nanjing Leads Biolabs Showcases Next-Generation Cancer ADCs at 2026 AACR Meeting
Premium
Company Announcements
Nanjing Leads Biolabs Showcases Next-Generation Cancer ADCs at 2026 AACR Meeting
15d ago
9887
Nanjing Leads Biolabs Reshapes Board With Non-Executive Director Change
Premium
Company Announcements
Nanjing Leads Biolabs Reshapes Board With Non-Executive Director Change
19d ago
9887
Nanjing Leads Biolabs Sets Out Board Composition and Committee Roles
Premium
Company Announcements
Nanjing Leads Biolabs Sets Out Board Composition and Committee Roles
19d ago
9887
Nanjing Leads Biolabs Advances Lead Cancer Therapy and Bolsters Pipeline in 2025
Premium
Company Announcements
Nanjing Leads Biolabs Advances Lead Cancer Therapy and Bolsters Pipeline in 2025
19d ago
9887
Nanjing Leads Biolabs Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Nanjing Leads Biolabs Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
29d ago
9887
Nanjing Leads Biolabs Added to Hang Seng Composite Index and Stock Connect Southbound List
Premium
Company Announcements
Nanjing Leads Biolabs Added to Hang Seng Composite Index and Stock Connect Southbound List
1M ago
9887
More HK:9887 News >

9887 News on the Web

Nanjing Leads Biolabs Advances Key Bispecific Antibody Into Phase II Expansion for Biliary Tract Cancer
TipRanks News
Bullish
Nanjing Leads Biolabs Co., Ltd. Class H (9887) Receives a Buy from CLSA
TipRanks News
Neutral
CMB International Securities Reaffirms Their Buy Rating on Nanjing Leads Biolabs Co., Ltd. Class H (9887)
TipRanks News
Bullish
Nanjing Leads Biolabs Showcases Next-Generation Cancer ADCs at 2026 AACR Meeting
TipRanks News
Bullish
Nanjing Leads Biolabs Reshapes Board With Non-Executive Director Change
TipRanks News
Bullish
Nanjing Leads Biolabs Sets Out Board Composition and Committee Roles
TipRanks News
Neutral
Nanjing Leads Biolabs Advances Lead Cancer Therapy and Bolsters Pipeline in 2025
TipRanks News
Bullish
Orient Securities Sticks to Their Buy Rating for Nanjing Leads Biolabs Co., Ltd. Class H (9887)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:9887’s Media Buzz Sentiment?
Currently, no data Available
What is HK:9887’s weekly average amount of articles?
Currently, no data Available
What is HK:9887’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
GLMDGalmed Pharmaceuticals
ALLOAllogene Therapeutics
TXTMProText Mobility
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week